Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome - CISMeF
Proliferative vasculopathy and hydranencephaly-hydrocephaly syndromeOMIM Phenotype
Preferred Label : Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome;
Symbol : PVHH;
CISMeF acronym : EPV; PVHH;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Hydranencephaly, fowler type; Fowler syndrome; Encephaloclastic proliferative vasculopathy; Hydrocephaly/hydranencephaly due to cerebral vasculopathy; EPV;
Description : The proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome is a rare
autosomal recessive prenatally lethal disorder characterized by hydranencephaly, a
distinctive glomerular vasculopathy in the central nervous system and retina, and
diffuse ischemic lesions of the brain stem, basal ganglia, and spinal cord with calcifications.
It is usually diagnosed by ultrasound between 26 and 33 weeks' gestation (summary
by Meyer et al., 2010).;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the feline leukemia virus subgroup C receptor 2 gene (FLVCR2,
610865.0001);